Progenitor Cell Mobilizing Treatments Prevent Experimental Transplant Arteriosclerosis
Authors:
- Ebba BrakenhielmEBEbba Brakenhielm
- Caroline Freguin-BouillantCFCaroline Freguin-Bouillant
- Françoise LallemandFLFrançoise Lallemand
- Jean-Paul HenryJHJean-Paul Henry
- Olivier BoyerOBOlivier Boyer
- Christian ThuillezCTChristian Thuillez
- Didier PlissonnierDPDidier Plissonnier
- 1 August 2012
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 176 (2) , 657-665
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Progenitor Cell Therapy in Patients With Critical Limb Ischemia Without Surgical OptionsAnnals of Surgery, 2008
- Endothelial progenitor cells: Characterization, in vitro expansion, and prospects for autologous cell therapyCell Biology and Toxicology, 2007
- Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studiesThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Intramyocardial Implantation of CD133 + Stem Cells Improved Cardiac Function without Bypass SurgeryThe Heart Surgery Forum, 2007
- Allograft Vasculopathy Versus AtherosclerosisCirculation Research, 2006
- Aging, Progenitor Cell Exhaustion, and AtherosclerosisCirculation, 2003
- Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor CellsCirculation, 2002
- VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary diseaseThe Annals of Thoracic Surgery, 2000
- Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Cardiac Allograft VasculopathyCirculation, 1997